"Biosimilars" is a term that people with arthritis will see more and more as the U.S. Food and Drug Administration (FDA) figures out how they will be reviewed and licensed. Most people think of biosimilars as generic biologic drugs. Well, sort of. Technically, though, the terms "biosimilars" and "generics" are not considered synonymous.
The Supreme Court's ruling on the Affordable Care Act has paved the way for expedited approval of biosimilars. Many companies have biosimilars currently in development. Learn more in Biosimilars - What You Need to Know.
Related Articles:
- Biologic Drugs Explained
- TNF Blockers - What You Need to Know
- Orencia - 10 Things You Should Know
- Self-Injection of Arthritis Drugs
Follow Me:
Facebook | Twitter | Message Board | Newsletter
No comments:
Post a Comment